Loading...

BillionToOne, Inc.

BLLN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$84.74
$0.81(0.97%)
U.S. Market opens in 23h 3m

BillionToOne, Inc. (BLLN) Stock Overview

Explore BillionToOne, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio1199.10
EPS (TTM)$0.14
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$80.67
3 Months$47.78
1 Year Target$31.99

BLLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BillionToOne, Inc. (BLLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $31.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 1199.10 and a market capitalization of 3.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.97%
5-Day Change
4.63%
1-Month Change
14.39%
3-Month Change
-3.23%
6-Month Change
-22.21%
Year-to-Date (YTD) Change
3.54%
1-Year Change
-22.21%
3-Year Change
-22.21%
5-Year Change
-22.21%
All-Time (Max) Change
-22.21%

Contact Information

https://www.billiontoone.com
(650) 460-2551
1035 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

620 Employees
IPO DateNov 6, 2025
CountryUS
Actively Trading

Frequently Asked Questions